Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Roche (4 pharmaceutical products)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of pharmaceutical products. The portfolio comprises of four products namely Marcoumar, an anticoagulant, Torem , a loop diuretic, Tilcotil , a drug for the treatment of painful inflammatory and degenerative disorders of the musculoskeletal system and Aurorix , a well-known antidepressant.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland

Roche (4 pharmaceutical products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Roche (4 pharmaceutical products)‘s full profile, request access.

Request full access to PitchBook

Roche (4 pharmaceutical products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Roche (4 pharmaceutical products)‘s full profile, request access.

Request full access to PitchBook